İngilizce
Arapça
Çince
Rusça
Türkçe
Uygulama Alanı
V300 nerede fark yaratır.
- Acil Laboratuvarı
- Klinik Departman
- Tıp Merkezi
- Muayene ve Tetkik Merkezi
- Araştırma Laboratuvarı
Test Hızı
<10s
Sonuç süresi 10 saniyenin altında
Her testte. Her zaman.
İmmünofloresans Reaktifi
Kapsamlı bir
biyobelirteç paneli.
V300; inflamasyon, hormonlar, kardiyak belirteçler, onkoloji, enfeksiyon hastalıkları ve daha fazlasını kapsayan geniş bir immünofloresans reaktif kartı yelpazesini destekler.
İnflamasyon (İltihap)
CRP
PCT
SAA
IL-6
HBP
HNL
Cinsiyet Hormonları
PROG
FSH
LH
β-HCG
PRL
Cortisol
AMH
Testosterone
E2
INH B
Tiroid Hormonları
TSH
T3
T4
FT3
FT4
Enfeksiyon Hastalıkları
SARS-CoV-2
Influenza A/B
RSV
Strep A
Adenovirus
HIV
HCV
Dengue NS1
CMV IgG/IgM
Kardiyak Belirteçler
CK-MB
cTnI
hs-cTnI
Myoglobin
NT-proBNP
BNP
D-Dimer
ST2
Tümör Belirteçleri
CEA
AFP
PSA
CA15-3
CA125
CA19-9
VEGF
TK1
Diyabet
HbA1c
C-Peptide
INS
Büyüme Hormonu
GH
Böbrek Fonksiyonu
NGAL
mAlb
CysC
β2-MG
Mide Sağlığı
PG I/II
HP-Ag
FOB
Gastrin-17
Calprotectin
Anemi
VB12
Ferritin
Folic Acid
Nöroloji
S100β
P-Tau-181
Aβ1-42
Romatizma
CCP
ASO
RF
RA33
TPO
ANA
Diğerleri
25-OH VD
IgE
Lp-PLA2
αx-LDL
BGP
PTH
BAP
PAPPA-A
Teknik Özellikler
Her ayrıntı önemlidir.
Prensip
Floresan immünoassay temeline dayanarak örneklerdeki maddeleri tespit eder |
Numune Türü
Tam Kan, Serum, Plazma, İdrar, Beyin Omurilik Sıvısı (BOS), Doku Biyopsisi, Tükürük, Bronkoalveoler Lavaj (BAL), Sinovyal Sıvı, Plevral Sıvı |
Ekran Boyutu
8.1 inç dokunmatik ekran |
Güç Kaynağı
AC 100–240V, 50/60Hz |
İşletim Sistemi
Android |
Ağırlık
3.00 KG |
Boyut
325 mm x 159 mm * 202 mm |
Test Kanalı
Tekli |
Test Hızı
Bir testin süresi < 10 saniye |
Test Öğeleri
255 |
Kart Başına Öğe
Kart başına birden fazla öğe desteklenir |
Veri Depolama Hacmi
10000 |
Dil Arayüzü
Çince, İngilizce (özelleştirilebilir) |
Yazıcı
Dahili termal yazıcı, harici yazıcıları destekler |
Reaktif Kart Kodu
Bar code, QR code (customized) |
Uygulanabilir Kart Türü
Kimlik kartı |
İmmünofloresan Reaktifi
| Category | Test Item | Item No | Sample | Reaction Time | Linearity Range | Refrence |
|---|---|---|---|---|---|---|
| Infection | CRP | SA.02.00002 (SEMI) / SJ.02.00002 (AUTO) | Serum / Plasma | 3 min | 0.5-200 mg/L | 10 > mg/L |
| Infection | PCT | SA.02.00004 (SEMI) / SJ.02.00004 (AUTO) | Serum / Plasma | 15 min | 0.1-100 ng/mL | 0.5 > ng/mL |
| Infection | SAA | SA.02.00005 (SEMI) / SJ.02.00005 (AUTO) | Serum / Plasma | 15 min | 2.0-100 mg/mL | 10 > mg/mL |
| Infection | IL-6 | SA.02.00006 (SEMI) / SJ.02.00006 (AUTO) | Serum / Plasma | 15 min | 3.0-4000 pg/mL | 7.5 > pg/mL |
| Infection | CRP / SAA | SA.02.00007 (SEMI) / SJ.02.00007 (AUTO) | Serum / Plasma | 15 min | CRP: 0.5-150 mg/L / SAA: 0.5-300 mg/L | CRP < 8.28 mg/L / SAA < 10 mg/L |
| Infection | PCT / IL-6 | SA.02.00008 (SEMI) / SJ.02.00008 (AUTO) | Serum / Plasma | 15 min | IL-6: 10-1000 pg/mL / PCT: 0.1-40 ng/mL | IL-6 < 15 pg/mL / PCT < 0.5 ng/mL |
| Infection | HBP / PCT | SA.02.00053 (SEMI) / SJ.02.00053 (AUTO) | Plasma | 15 min | HBP: 1-200 ng/mL / PCT: 0.05-50 ng/mL | HBP < 15 ng/mL / PCT < 0.5 ng/mL |
| Infection | HBP | SA.02.00054 (SEMI) / SJ.02.00054 (AUTO) | Plasma | 15 min | 5-300 ng/mL | 15 > ng/mL |
| Sex Hormone | PROG | SA.02.00009 (SEMI) / SJ.02.00009 (AUTO) | Serum / Plasma | 15 min | 1.2-120 nmol/L | Follicular: 0.6–1.9 nmol/L; Oviposit: 0.95–6.68; Luteal: 6.8–72; Pregnancy 1st: 48.97–190.8; Menopause: 0.32–2.0; Male: 0.31–2.67 |
| Sex Hormone | FSH | SA.02.00010 (SEMI) / SJ.02.00010 (AUTO) | Serum / Plasma | 15 min | 2-100 IU/L | Follicular: 1.5–7.5; Oviposit: 2.8–12.5; Luteal: 1.8–5.0; After menopause: 15.0–76.0; Male: 1.25–19.62 |
| Sex Hormone | LH | SA.02.00011 (SEMI) / SJ.02.00011 (AUTO) | Serum / Plasma | 15 min | 2-100 IU/L | Follicular: 2–12.5; Oviposit: 13–106; Luteal: 0.5–10.5; After menopause: 7.6–25.2; Male: 1.15–6.85 |
| Sex Hormone | β-HCG | SA.02.00012 (SEMI) / SJ.02.00012 (AUTO) | Serum / Plasma | 15 min | 4-10000 mIU/mL | 10 > mIU/mL |
| Sex Hormone | PRL | SA.02.00013 (SEMI) / SJ.02.00013 (AUTO) | Serum / Plasma | 15 min | 40-3000 μIU/mL | Premenopausal: 74–566; Postmenopausal: 68–528; Male: 63–350 μIU/mL |
| Sex Hormone | Cor | SA.02.00014 (SEMI) / SJ.02.00014 (AUTO) | Serum / Plasma | 15 min | 0.5 μg/dL–36 μg/dL | 3.56–22.73 μg/dL |
| Sex Hormone | AMH | SA.02.00015 (SEMI) / SJ.02.00015 (AUTO) | Serum / Plasma | 15 min | 0.1-24 ng/mL | 2–14 ng/mL |
| Thyroid Hormone | TSH | SA.02.00016 (SEMI) / SJ.02.00016 (AUTO) | Serum / Plasma | 15 min | 0.1-100 μIU/mL | 0.3-5.6 μIU/mL |
| Thyroid Hormone | T3 | SA.02.00017 (SEMI) / SJ.02.00017 (AUTO) | Serum / Plasma | 15+10 min | 0.77-6.0 nmol/L | 1.34-2.73 nmol/L |
| Thyroid Hormone | T4 | SA.02.00018 (SEMI) / SJ.02.00018 (AUTO) | Serum / Plasma | 15 min | 15-300 nmol/L | 78.51-157.01 nmol/L |
| Thyroid Hormone | FT3 | SA.02.00057 (SEMI) / SJ.02.00057 (AUTO) | Serum / Plasma | 10 min | 1.6-46 pmol/L | 3.1-6.8 pmol/L |
| Thyroid Hormone | FT4 | SA.02.00058 (SEMI) / SJ.02.00058 (AUTO) | Serum / Plasma | 10 min | 3.2-77.2 pmol/L | 11.5-22.7 pmol/L |
| Cardiac Marker | CK-MB | SA.02.00001 (SEMI) / 5102.00001 (AUTO) | Serum / Plasma | 15 min | 1-100 ng/mL | CK-MB < 5 ng/mL |
| Cardiac Marker | cTnI | 51.02.00019 (SEMI) / 5102.00019 (AUTO) | Serum / Plasma | 15 min | 0.1-40 ng/mL | < 0.5 ng/mL |
| Cardiac Marker | Myo | SA.02.00020 (SEMI) / 5102.00020 (AUTO) | Serum / Plasma | 15 min | 5-400 ng/mL | < 60 ng/mL |
| Cardiac Marker | NT-proBNP | SA.02.00021 (SEMI) / 51.02.00021 (AUTO) | Serum / Plasma | 15 min | 50-20000 pg/mL | 300 pg/mL (< 75 yrs), 450 pg/mL (≥ 75 yrs) |
| Cardiac Marker | H-FABP | SA.02.00022 (SEMI) / 5102.00022 (AUTO) | Serum / Plasma | 15 min | 3-100 ng/mL | < 7 ng/mL |
| Cardiac Marker | D-Dimer | SA.02.00023 (SEMI) / 5102.00023 (AUTO) | Serum / Plasma | 15 min | 0.1-10 mg/L | < 0.5 mg/L |
| Cardiac Marker | cTnI / Myo / CK-MB (3 in 1) | SA.02.00024 (SEMI) / 5102.00024 (AUTO) | Serum / Plasma | 15 min | cTnI: 0.1-40 ng/mL, CK-MB: 1-100 ng/mL, Myo: 5-400 ng/mL | cTnI < 0.3 ng/mL, CK-MB < 5 ng/mL, Myo < 60 ng/mL |
| Cardiac Marker | cTnI / NT-proBNP | 51.02.00025 (SEMI) / 5102.00025 (AUTO) | Serum / Plasma | 15 min | cTnI: 0.1-40 ng/mL, NT-proBNP: 50-20000 pg/mL | cTnI < 0.5 ng/mL, NT-proBNP: 300 pg/mL (< 75 yrs), 450 pg/mL (≥ 75 yrs) |
| Cardiac Marker | cTnT | SA.02.00052 (SEMI) / 5102.00052 (AUTO) | Serum / Plasma / Whole Blood | 15 min | 30.0–10000.0 pg/mL | > 100 pg/mL |
| Kidney | NGAL | SA.02.00026 (SEMI) / 5102.00026 (AUTO) | Serum / Plasma | 10 min | 50-1000 ng/mL | > 60 ng/mL |
| Kidney | mAlb | SA.02.00027 (SEMI) / S102.00027 (AUTO) | Urine | 15 min | 5-300 mg/L | 0-20 mg/L |
| Kidney | CysC | SA.02.00028 (SEMI) / 5102.00028 (AUTO) | Serum / Plasma | 5 min | 0.2-10 mg/L | 0.5-1.1 mg/L |
| Kidney | β2-MG | SA.02.00029 (SEMI) / SA02.00029 (AUTO) | Serum / Plasma | 15 min | 0.3-20 mg/L | 1.0-2.7 mg/L |
| Diabetes | HbA1c | SA.02.00030 (SEMI) / SA02.00030 (AUTO) | Whole Blood | 15 min | 2-14% | 3.8 - 5.8% |
| Gastric Function | PG I | SA.02.00033 (SEMI) / 5102.00033 (AUTO) | Serum / Plasma | 15 min | 70-200 ng/mL | < 20 ng/mL |
| Gastric Function | PG I | SA.02.00033 (SEMI) / 5102.00033 (AUTO) | Serum / Plasma | 15 min | 5-200 ng/mL | 2.5-100 ng/mL |
| Gastric Function | G17 | SA.02.00056 (SEMI) / 5102.00056 (AUTO) | Serum / Plasma | 15 min | 1-50 pmol/L | 1-7 pmol/L |
| Cancer | CEA | SA02.00034 (SEMI) / 51.02.00034 (AUTO) | Serum / Plasma | 15 min | 2.5-1000 ng/mL | > 35 ng/mL |
| Cancer | AFP | SA.02.00035 (SEMI) / 51.02.00035 (AUTO) | Serum / Plasma | 15 min | 5-1000 ng/mL | > 25 ng/mL |
| Cancer | PSA | SA02.00036 (SEMI) / S1.02.00036 (AUTO) | Serum / Plasma | 15 min | 2.0-100.0 ng/mL | > 4 ng/mL |
| Cancer | DO | SA.02.00055 (SEMI) / S102.00055 (AUTO) | Serum / Plasma | 15 min | 1-20 pmol/L | > 2 pmol/L |
| Infectious Disease | SARS‑CoV‑2 Ag | SA.02.00037 (SEMI) / 51.02.00037 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Dengue IgG / IgM | SA.02.00038 (SEMI) / 51.02.00038 (AUTO) | Serum / Plasma / Whole blood | 15 min | / | / |
| Infectious Disease | SARS‑CoV‑2 / Flu A+B | SA.02.00039 (SEMI) / 51.02.00039 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | SARS‑CoV‑2 IgG / IgM | SA.02.00040 (SEMI) / 51.02.00040 (AUTO) | Serum / Plasma | 15 min | / | / |
| Infectious Disease | HP‑Ab | SA.02.00041 (SEMI) / 51.02.00041 (AUTO) | Serum / Plasma | 15 min | / | / |
| Infectious Disease | HP‑Ag | SA.02.00042 (SEMI) / 51.02.00042 (AUTO) | Feces | 15 min | / | / |
| Infectious Disease | FOB | SA.02.00043 (SEMI) / 51.02.00043 (AUTO) | Feces | 15 min | / | / |
| Infectious Disease | P. falciparum / Pan | SA.02.00044 (SEMI) / 51.02.00044 (AUTO) | Whole blood | 15 min | / | / |
| Infectious Disease | RSV | SA.02.00045 (SEMI) / 51.02.00045 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Influenza A / B | SA.02.00046 (SEMI) / 51.02.00046 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Strep A | SA.02.00047 (SEMI) / 51.02.00047 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Adenovirus | SA.02.00048 (SEMI) / 51.02.00048 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Mycoplasma IgG / IgM | SA.02.00049 (SEMI) / 51.02.00049 (AUTO) | Serum / Plasma / Whole blood | 15 min | / | / |
| Infectious Disease | Influenza A / B + H1N1 | SA.02.00050 (SEMI) / 51.02.00050 (AUTO) | Naso / Oropharyngeal swab | 15 min | / | / |
| Infectious Disease | Dengue NS1 Ag | SA.02.00051 (SEMI) / 51.02.00051 (AUTO) | Serum / Plasma / Whole blood | 15 min | / | / |
| Others | 25-OH-VD | SA.02.0°D31 (SEMI) / 51.02.00031 (AUTO) | Serum / Plasma | 10 min | 8–80 ng/mL | 30–80 ng/mL |
| Others | IgE V812 | SA.02.00032 (SEMI) / 51.02.00032 (AUTO) | Serum / Plasma | 15 min | 8–1000 IU/mL | Neonatal: 0–1.5 IU/mL; <1 yr: 0–15 IU/mL; 1–5 yrs: 0–90 IU/mL; 6–9 yrs: 0–90 IU/mL; 10–15 yrs: 0–200 IU/mL; Adult: 0–100 IU/mL |
| Others | Vitamin D Related Test | SA.02.00059 (SEMI) / 51.02.00059 (AUTO) | Serum / Plasma | 15 min | 150–1500 pg/mL | 240–800 pg/mL |
| Sex Hormone | Sex Hormone HCG (GICA) | SA.03.00010 (SEMI) / S1.03.00010 (AUTO) | Urine | 5 min | ||
| Sex Hormone | LH (GICA) | SA.03.00002 (SEMI) / S1.03.00002 (AUTO) | Urine | 5 min | ||
| Infectious Disease | HP-Ab (GICA) | SA.03.00003 (SEMI) / 51.03.00003 (AUTO) | Serum / Plasma | 15 min | ||
| Infectious Disease | HP-Ag (GICA) | SA.03.00004 (SEMI) / 51.03.00004 (AUTO) | Feces | 15 min | ||
| Infectious Disease | SARS-Cov-2 (LIA) | SA.03.00005 (SEMI) / 5103.00005 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | SARS-Cov-2 (GICA) | SA.03.00006 (SEMI) / 5103.00006 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | Flu A / B (GICA) | SA.03.00007 (SEMI) / 51.03.00007 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | SARS-Cov-2 / Flu A+B (GICA) | SA.03.00008 (SEMI) / 5103.00008 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | SARS-CoV-2 IgG / IgM (GICA) | SA.03.00009 (SEMI) / 51.03.00009 (AUTO) | Serum / Plasma | 15 min | ||
| Infectious Disease | InBuenza A / B (LIA) | SA.03.00011 (SEMI) / 51.03.00011 (AUTO) | Naso / Oropharyngeal swab | 15 min | ||
| Infectious Disease | Dengue IgG / IgM (GICA) | SA.03.00012 (SEMI) / S./03.00012 (AUTO) | Serum / Plasma / Whole blood | 15 min | ||
| Infectious Disease | Dengue NS1 Ag (GICA) | SA.03.00013 (SEMI) / 51.03.00013 (AUTO) | Serum / Plasma / Whole blood | 15 min |
